Divisions

Our academic divisions correspond to the stages in the drug development cycle.

Stage 1: Discovery

Chemical Biology and Medicinal Chemistry

Our work focuses on discovering new therapeutic agents and targets. Thousands of compounds researched here at the UNC Eshelman School of Pharmacy have the potential for therapeutic applications impacting many disease targets, such as enzymes, specific drug receptors, and even the genome.

Stage 2: Delivery

Pharmacoengineering and Molecular Pharmaceutics

We are engaged in education and research in targeted drug delivery that will ensure optimal therapeutic efficacy of pharmacologically and immunologically active agents. It is a multidisciplinary endeavor requiring knowledge in basic pharmaceutics, chemistry, biopharmaceutics, pharmacokinetics, drug metabolism, and pharmaceutical analysis.

Stage 3: Optimization

Pharmacotherapy and Experimental Therapeutics

We work to optimize drug therapy through the generation, integration, and translation of scientific information between the bench and the bedside, the patient and the population. We advance clinical practice through innovative translational research and through the education and training of clinical scientists, future pharmacists and current practitioners.

Stage 4: Practice

Practice Advancement and Clinical Education

We support and advance the practice of pharmacy by providing innovative education and training experiences for pharmacists, both present and future, demonstrating professional leadership, modeling cutting-edge practice and engaging in practiced-based scholarship.

Stage 5: Assessment

Pharmaceutical Outcomes and Policy

We study the effectiveness and costs of medications, how patients take their medications, and the impact of drug policies on health outcomes of vulnerable people. Our research focuses on health outcomes of patients with chronic medical conditions and the roles of pharmacists in medication therapy management.